GlassScriptPhysician profile
Samuel C Docena
NPI 1376600973
$3,394.24
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $1,036 · 2021: $1,113 · 2022: $194.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $512.68 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $510.85 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $460.77 | 2019-2021 | |
| Novo Nordisk INC | $318.23 | 2019-2021 | |
| Amarin Pharma, INC. | $233.06 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $201.79 | 2020-2022 | |
| Glaxosmithkline, LLC. | $200.85 | 2019-2021 | |
| Lilly USA, LLC | $111.93 | 2019-2022 | |
| Pfizer INC. | $102.91 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $96.84 | 2019-2021 | |
| Allergan, INC. | $64.33 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.01 | 2021-2022 | |
| Abbott Laboratories | $57.40 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.17 | 2019-2021 | |
| Horizon Therapeutics Plc | $48.43 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40.61 | 2021 | |
| Esperion Therapeutics, INC. | $39.80 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $37.40 | 2019-2021 | |
| Mannkind Corporation | $34.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.56 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.72 | 2019 | |
| Eisai INC. | $20.93 | 2021 | |
| Alk-Abello, INC | $19.51 | 2019 | |
| Dexcom, INC. | $19.16 | 2021 | |
| Astellas Pharma US INC | $18.95 | 2020 | |
| Amgen INC. | $18.71 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.52 | 2021 | |
| Melinta Therapeutics, LLC | $16.70 | 2019 | |
| Nabriva Therapeutics, Plc | $13.42 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $10.98 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Docena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.